Table 1.
Summary of patients and secondary tumor characteristics
| Case no. | Recipient sex | Age at diagnosis (years) | Primary disease | Type of HSCT | Interval between transplant and diagnosis (years) | Site of secondary tumor | Pathological diagnosis | UICC TNM Seventh |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 37 | AML | ur-BMT | 19.8 | Breast | Invasive ductal carcinoma | T2N1M0 |
| 2 | M | 64 | CML | ur-BMT | 18.5 | Liver | Hepatocellular carcinoma | T1N0M0 |
| 3 | M | 66 | MDS | ur-BMT | 3.6 | Oral mucosa | Squamous cell carcinoma | T1N0M0 |
| 4 | M | 67 | MPN/MDS | ur-BMT | 3.9 | Stomach | Adenocarcinoma | TisN0M0 |
| 5 | M | 68 | MCL | ur-BMT | 7.8 | Colon | Adenocarcinoma | TisN0M0 |
| 6 | F | 58 | Ph+ ALL | ur-BMT | 2.4 | Colon | Adenoma with high-grade dysplasia | Not available |
F female, M male, AML acute myeloid leukemia, CML chronic myelogenous leukemia, MDS myelodysplastic syndromes, MPN/MDS myelodysplastic/myeloproliferative neoplasms, MCL mantle cell lymphoma, Ph+ ALL Philadelphia chromosome-positive acute lymphoblastic leukemia, HSCT hematopoietic stem cell transplant, ur-BMT bone marrow transplants from unrelated donors, UICC TNM Seventh UICC TNM Classification of Malignant Tumors, Seventh Edition